Z
Zedsen
Non-invasive electrical tomography sensors for oncological diagnostics
About Zedsen
Zedsen is a UK-based health technology company founded in 2014 by Sir Charles Masefield, Daniel Honeywell, Paul Honeywell, and Dr. Hrand Mamigonians. The company is developing non-invasive sensor technology that utilizes Electrical Capacitance Tomography (ECT) to analyze biological tissues. This technology, which has 46 global patents, creates 3D electrical fields to measure the electrical properties of materials, such as human tissue, without radiation or breaking the skin. The data is then processed by algorithms to identify different materials and structures, with an initial focus on differentiating between healthy and malignant tissue for cancer detection.
Read full description
The company's primary product in development is the Z-Scanner, a portable device that uses a flat array of parallel electrodes, removing the need for the painful compression associated with conventional ECT methods. Zedsen has partnered with Imperial College Healthcare NHS Trust to conduct a clinical study at Charing Cross Hospital throughout 2024 to validate the technology's ability to differentiate between benign and cancerous lesions. The long-term vision is to provide an affordable and portable diagnostic tool suitable for use in primary care and community clinic settings to improve early access to cancer diagnostics.
In July 2023, Michael Lynch and Martin Harriman, known for their success with WaveOptics, joined as CEO and Chairman, respectively, to guide Zedsen through its clinical trials and commercialization phase. The company has secured significant funding, including a Series B round of $12 million in April 2021, which valued the company at $110 million. Key investors include Oppenheimer, Rubellite Holdings, Joseph R. Grano, and Nasser Kazeminy.
At a glance
- Status
- Operational
- Founded
- 2015
- Headquarters
- London, United Kingdom
- Employees
- 22
- Open positions
- None listed
- Dealroom signal
- 74.7/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Health Tech & Medtech, Remote Monitoring, Tech for Patients, EIT Health, Drug Delivery Systems, EIT Ecosystem, Horizon Europe, Digital Care, remote health monitoring
- Technology
- 3D Technology, Deep Tech
- Business model
- Manufacturing
- Client focus
- b2b
Latest news
Press, funding announcements and product moves mentioning Zedsen.
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| GRANT✓Other financing | Apr 2025 | $218K | — | UK Research and Innovation | — |
| SUPPORT PROGRAM✓Other financing | Jan 2025 | $0 | — | EIT Health | — |
Growth signals
Latest recorded traffic for Zedsen is 350 monthly website visits, down 12.5% over the last three months. Zedsen's team grew 10% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
| Company | Headquarters | Status | Employees | Total funding | Valuation |
|---|---|---|---|---|---|
GiveVisionRetaining your sight for longer |
London, United Kingdom | Operational | 12 | $1.6M | $1.3M |
BiovotionWearable physiology monitoring company |
London, United Kingdom | Acquired | |||
AcurableWearable acoustic sensors for automated respiratory condition diagnosis |
London, United Kingdom | Operational | |||
AparitoPlatform digitizing clinical trials with patient-generated data |
Wrexham, United Kingdom | Acquired | |||
Syrona HealthDigital therapeutics for Endometriosis and Gynaecological Health |
London, United Kingdom | Operational | |||
PCL HealthRemote patient monitoring and health analytics ecosystem |
London, United Kingdom | Operational | |||
11HealthSensor connected to your smartphone that alerts you as to how full your ostomy bag is |
Elstree and Borehamwood, United Kingdom | Operational | |||
PneumoWaveWearable biosensor platform for remote respiratory monitoring |
Edinburgh, United Kingdom | Operational |
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
UK Research and Innovation
Series A5 investors entered at this stage
- JHJim Harpel
- NKNasser Kazeminy
JOSEPH GRANO- TRTony Rice
- BHBonnie Mcalveen Hunter
Other known investors1 additional known investor
EIT Health
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Zedsen on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Zedsen’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







